dolichol-d-glucosylmonophosphate has been researched along with 1,2,5,8-tetrahydroxy anthraquinone in 1 studies
| Studies (dolichol-d-glucosylmonophosphate) | Trials (dolichol-d-glucosylmonophosphate) | Recent Studies (post-2010) (dolichol-d-glucosylmonophosphate) | Studies (1,2,5,8-tetrahydroxy anthraquinone) | Trials (1,2,5,8-tetrahydroxy anthraquinone) | Recent Studies (post-2010) (1,2,5,8-tetrahydroxy anthraquinone) |
|---|---|---|---|---|---|
| 35 | 0 | 1 | 48 | 0 | 34 |
| Protein | Taxonomy | dolichol-d-glucosylmonophosphate (IC50) | 1,2,5,8-tetrahydroxy anthraquinone (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 4.4 | |
| Tissue-type plasminogen activator | Homo sapiens (human) | 4.4 | |
| Plasminogen activator inhibitor 1 | Homo sapiens (human) | 4.4 | |
| Urokinase-type plasminogen activator | Mus musculus (house mouse) | 4.4 | |
| Casein kinase II subunit alpha | Rattus norvegicus (Norway rat) | 0.11 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 3.0815 | |
| Casein kinase II subunit beta | Rattus norvegicus (Norway rat) | 0.11 | |
| Casein kinase II subunit alpha | Homo sapiens (human) | 0.11 | |
| Integrase | Human immunodeficiency virus 1 | 2.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briggs, JM; Bushman, FD; Carlson, HA; Jorgensen, WL; Lins, RD; Masukawa, KM; McCammon, JA; Rubins, K | 1 |
1 other study(ies) available for dolichol-d-glucosylmonophosphate and 1,2,5,8-tetrahydroxy anthraquinone
| Article | Year |
|---|---|
Developing a dynamic pharmacophore model for HIV-1 integrase.
Topics: Computer Simulation; Drug Evaluation, Preclinical; HIV Integrase; HIV Integrase Inhibitors; Models, Chemical; Models, Molecular; Protein Conformation; Structure-Activity Relationship | 2000 |